NOT-GM-21-005: Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing Access to Research Careers (T34 Clinical Trial Not Allowed)

Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing Access to Research Careers (T34 Clinical Trial Not Allowed)

Notice Number:

NOT-GM-21-005

Key Dates

Release Date:

December 10, 2020

Estimated Publication Date of Funding Opportunity Announcement:

February 17, 2021

First Estimated Application Due Date:

May 21, 2021

Earliest Estimated Award Date:

April 01, 2022

Earliest Estimated Start Date:

April 01, 2022

Related Announcements

PAR-19-219 - Maximizing Access to Research Careers (T34)

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The National Institute of General Medical Sciences (NIGMS) intends to reissue PAR-19-219 "Maximizing Access to Research Careers (MARC)" with minor modifications. Modifications to the planned Funding Opportunity Announcement (FOA) include an emphasis on promoting safety in the research training environment and teaching to the highest practices in biomedical research.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications.

The FOA is expected to be published before the Spring of 2021 with an expected application due date in Spring 2021.

The FOA will utilize the T34 activity code.

Research Initiative Details

This funding opportunity aims to develop a diverse pool of undergraduates who complete their baccalaureate degree, and transition into and complete biomedical, research-focused higher degree programs (e.g., Ph.D. or M.D./Ph.D.). This FOA provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise.

For diversity enhancing programs, NIGMS recognizes separate institutional eligibility tracks: research-intensive, i.e., those with an average of NIH research project grant (RPG) funding greater than or equal to $7.5 million total costs over the past 3 fiscal years; and research-active, i.e., those with an average of RPG funding less than $7.5 million total costs over the last 3 fiscal years (RPG data are available through NIH RePORT). For example, prospective applicants for this funding opportunity in FY 2021 should review their RPG funding for FYs 2018, 2019, and 2020 to determine eligibility. Institutional eligibility for this FOA is limited to baccalaureate degree-granting research-intensive institutions.

Funding Information

Estimated Total Funding

TBD

Expected Number of Awards

TBD

Estimated Award Ceiling

TBD

Primary CFDA Numbers

93.859

Anticipated Eligible Organizations

Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Indian/Native American Tribal Government (Other than Federally Recognized)
U.S. Territory or Possession
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
Indian/Native American Tribal Government (Federally Recognized)

Applications are not being solicited at this time.

Inquiries

Please direct all inquiries to:

Sydella Blatch, Ph.D.
National Institute of General Medical Sciences
[email protected]

Patrick H. Brown, Ph.D.
National Institute of General Medical Sciences
Email:[email protected]